Literature DB >> 22182797

Echinocandins--first line in invasive candidiasis: how strong is this 'strong' evidence?

João Gonçalves-Pereira, Pedro Póvoa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22182797      PMCID： PMC3388707          DOI： 10.1186/cc10580

Source DB:  PubMed          Journal:  Crit Care        ISSN： 1364-8535            Impact factor:   9.097


× No keyword cloud information.
  8 in total

1.  Echinocandins--an advance in the primary treatment of invasive candidiasis.

Authors:  Thomas J Walsh
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

Review 2.  Statistical issues in interpreting clinical trials.

Authors:  D L DeMets
Journal:  J Intern Med       Date:  2004-05       Impact factor: 8.989

3.  Lessons from and cautions about noninferiority and equivalence randomized trials.

Authors:  Peter C Gøtzsche
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

4.  Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

Authors:  J H Rex; T J Walsh; J D Sobel; S G Filler; P G Pappas; W E Dismukes; J E Edwards
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

Review 5.  Treatment of candidemia in adult patients without neutropenia--an inconvenient truth.

Authors:  Pedro Póvoa; João Gonçalves-Pereira
Journal:  Crit Care       Date:  2011-01-31       Impact factor: 9.097

6.  Anidulafungin versus fluconazole for invasive candidiasis.

Authors:  Annette C Reboli; Coleman Rotstein; Peter G Pappas; Stanley W Chapman; Daniel H Kett; Deepali Kumar; Robert Betts; Michele Wible; Beth P Goldstein; Jennifer Schranz; David S Krause; Thomas J Walsh
Journal:  N Engl J Med       Date:  2007-06-14       Impact factor: 91.245

7.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

8.  Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis.

Authors:  Daniel H Kett; Andrew F Shorr; Annette C Reboli; Arlene L Reisman; Pinaki Biswas; Haran T Schlamm
Journal:  Crit Care       Date:  2011-10-25       Impact factor: 9.097
  8 in total
  1 in total

1.  ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.

Authors:  Ignacio Martin-Loeches; Massimo Antonelli; Manuel Cuenca-Estrella; George Dimopoulos; Sharon Einav; Jan J De Waele; Jose Garnacho-Montero; Souha S Kanj; Flavia R Machado; Philippe Montravers; Yasser Sakr; Maurizio Sanguinetti; Jean-Francois Timsit; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2019-03-25       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.